NLRP3 and cystic fibrosis: ■In vitro and in vivo inflammatory response suppression of alveolar epithelial cells via reduction in the TLR4/NF-κB/NLRP3 inflammasome pathway [45];■Improved clinical score of adult CF patients [54].